Clinical Report: Network Meta-Analysis of Treatment Modalities for NPC

Overview

This study systematically compares the efficacy of induction chemotherapy, targeted therapy, and radiotherapy in nasopharyngeal carcinoma (NPC) patients.

Background

Nasopharyngeal carcinoma (NPC) presents a significant disease burden, particularly in endemic regions. The optimal treatment strategy remains debated, with various modalities including induction chemotherapy, targeted therapy, and radiotherapy.

Data Highlights

Key Findings

• Induction chemotherapy (IC) demonstrated a statistically significant survival benefit compared to the control group (HR = 0.37, 95% CI: 0.02, 0.71).
• Targeted therapy (TD) ranked first in overall survival probability (SUCRA = 98.1%) but did not show significant benefits in OS.
• No intervention showed statistically significant benefits for progression-free survival (PFS).
• IC had the highest probability for objective response rate (ORR) (SUCRA = 71.6%) with no significant differences among interventions.
• TD showed the greatest advantage in cumulative recurrence risk reduction (SUCRA = 98.0%).
• Radiotherapy alone did not demonstrate significant benefits across any outcome measures.

Clinical Implications

The findings suggest that induction chemotherapy should be prioritized for improving overall survival in NPC patients. Targeted therapies may be more effective in managing recurrence risk, while radiotherapy alone may not provide significant benefits.

Conclusion

This network meta-analysis provides evidence for the comparative efficacy of treatment modalities in nasopharyngeal carcinoma.

Related Resources & Content

1. The ASCO Post, June 2023 -- Role of Chemotherapy in Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Radiotherapy
2. The ASCO Post, March 2026 -- Metabolic Subtypes of Nasopharyngeal Carcinoma and Response to Treatment
3. Frontiers in Oncology -- Efficacy, long-term survival and safety of different PD-1 inhibitors plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
4. NCCN GUIDELINES® INSIGHTS -- Head and Neck Cancers
5. Frontiers in Medicine — Comparing the effectiveness of various cumulative doses of cisplatin in treating locally advanced nasopharyngeal cancer during the period of intensity-modulated radiation treatment: A meta-analysis
6. Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
7. Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis
8. CE NCCN GUIDELINES® INSIGHTS Head and Neck Cancers